Widlitz Michael 4
4 · Immunome Inc. · Filed Oct 8, 2020
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Widlitz Michael
Director
Transactions
- Conversion
Common Stock
2020-10-06+51,315→ 51,315 total - Conversion
Series A Convertible Preferred Stock
2020-10-06−51,315→ 0 total→ Common Stock (51,315 underlying)
Footnotes (1)
- [F1]Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.